According to Perrigo's latest financial reports and stock price the company's current Operating Margin is -3.12%. At the end of 2022 the company had an Operating Margin of -3.12%.
Year | Operating Margin | Change |
---|---|---|
2022 | -3.12% | -149.99% |
2021 | 6.25% | -311.84% |
2020 | -2.95% | -183.47% |
2019 | 3.53% | -42.44% |
2018 | 6.14% | 8.45% |
2017 | 5.66% | -106.17% |
2016 | -91.81% | -1804.43% |
2015 | 5.39% | -19.76% |
2014 | 6.71% | -60.9% |
2013 | 17.17% | 6.4% |
2012 | 16.13% | -1.34% |
2011 | 16.35% | 20.4% |
2010 | 13.58% | 33.77% |
2009 | 10.15% | 2.54% |
2008 | 9.90% | 60.96% |
2007 | 6.15% | -20.62% |
2006 | 7.75% | -124% |
2005 | -32.29% | -373.67% |
2004 | 11.80% | 12.99% |
2003 | 10.44% | -2.33% |
2002 | 10.69% | 83.69% |
2001 | 5.82% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
United Therapeutics UTHR | 49.09% | -1,673.40% | ๐บ๐ธ USA |
Endo International
ENDPQ | -129.15% | 4,039.42% | ๐ฎ๐ช Ireland |
Intercept Pharmaceuticals
ICPT | -59.02% | 1,791.67% | ๐บ๐ธ USA |
Catalent CTLT | 4.60% | -247.44% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.